Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for AGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 257.25M
March 31, 2026 302.99M
December 31, 2025 285.14M
September 30, 2025 310.85M
June 30, 2025 327.00M
March 31, 2025 368.77M
December 31, 2024 405.60M
September 30, 2024 398.56M
June 30, 2024 407.96M
March 31, 2024 425.91M
December 31, 2023 495.10M
September 30, 2023 574.42M
Date Value
June 30, 2023 590.23M
March 31, 2023 826.89M
December 31, 2022 887.81M
September 30, 2022 972.47M
June 30, 2022 969.25M
March 31, 2022 1.036B
December 31, 2021 1.055B
September 30, 2021 1.096B
June 30, 2021 1.126B
March 31, 2021 119.49M
December 31, 2020 135.18M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Astrana Health, Inc. 402.14M
Starling Oncology, Inc. 41.09M
Nakamoto, Inc. 19.07M
American Oncology Network, Inc. --
Tenet Healthcare Corp. 2.17B